Market Overview

Canaccord Genuity Reiterates Buy Rating, $32 PT on IMAX Corporation

Share:
Related IMAX
Wedbush Securities Sees Solid Q4 Beat For IMAX
Earnings Scheduled For February 19, 2015

In a report published Monday, Canaccord Genuity reiterated its Buy rating and $32.00 price target on IMAX Corporation (NYSE: IMAX).

Canaccord Genuity noted, “We have reviewed our longer-term forecasts and have opted to use $1.1M as our standard box office PSA (per screen average) for IMAX on a go-forward basis in our projections. Based on the box office numbers we have seen through 2012, it is apparent that the final 2012 PSA is likely to be closer to $1.1M rather than $1.2M. We currently expect it will come in at $1.11M. This compares with $960K in F2011 and $1.65M in F2010.”

IMAX Corporation closed on Friday at $21.76.

Latest Ratings for IMAX

DateFirmActionFromTo
Feb 2015Canaccord GenuityDowngradesBuyHold
Feb 2015JP MorganDowngradesOverweightNeutral
Nov 2014Goldman SachsUpgradesNeutralBuy

View More Analyst Ratings for IMAX
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityAnalyst Color Reiteration Analyst Ratings

 

Related Articles (IMAX)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→